Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DAWN | US
0.21
1.56%
Healthcare
Biotechnology
31/03/2024
05/07/2024
13.71
13.44
13.81
13.27
Day One Biopharmaceuticals Inc. a clinical-stage biopharmaceutical company develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101 an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals Inc. was incorporated in 2018 and is headquartered in Brisbane California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Smallcap (300M - 2B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
30.1%1 month
52.2%3 months
68.4%6 months
62.6%-
-
3.47
0.00
0.00
-4.07
-
-
-221.92M
1.20B
1.20B
-
-
-
-
-69.97
12.68
14.70
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.18
Range1M
2.15
Range3M
6.13
Rel. volume
0.61
Price X volume
7.93M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Verona Pharma plc | VRNA | Biotechnology | 16.11 | 1.31B | 2.55% | n/a | 22.79% |
ANI Pharmaceuticals Inc | ANIP | Biotechnology | 61.44 | 1.29B | 1.02% | 39.55 | 68.66% |
Arcus Biosciences Inc | RCUS | Biotechnology | 14.12 | 1.28B | -1.67% | n/a | 1.56% |
Ardelyx Inc | ARDX | Biotechnology | 5.29 | 1.24B | -0.56% | n/a | 69.54% |
ARCUTIS BIOTHERAPEUTICS INC. | ARQT | Biotechnology | 10.49 | 1.21B | 9.27% | n/a | 91.91% |
immatics biotechnologies GmbH | IMTX | Biotechnology | 11.74 | 1.21B | -0.68% | n/a | 8.13% |
NRIX | NRIX | Biotechnology | 19.47 | 1.19B | 0.31% | n/a | 17.28% |
IRON | IRON | Biotechnology | 46.62 | 1.15B | 4.93% | n/a | 0.60% |
Sana Biotechnology Inc. Common Stock | SANA | Biotechnology | 5.09 | 1.13B | -2.49% | n/a | 28.28% |
4D Molecular Therapeutics Inc | FDMT | Biotechnology | 21.15 | 1.09B | 1.44% | n/a | 2.36% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 13.45 | 1.31B | -0.37% | n/a | 20.15% |
REV Group Inc | REVG | Recreational Vehicles | 24.74 | 1.28B | -2.06% | 5.86 | 66.74% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.36 | 1.14B | 1.60% | n/a | -628.58% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 17.73 | 799.13M | -2.42% | n/a | 4070.84% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 32.65 | 667.35M | -2.74% | n/a | 4.21% |
Ennis Inc | EBF | Building Products & Equipment | 21.25 | 552.16M | -0.75% | 13.68 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.48 | 428.47M | -2.40% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 25.77 | 412.92M | -1.68% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.74 | 369.15M | -2.49% | 14.12 | 86.68% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.36 | 324.63M | -2.40% | 10.10 | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -4.07 | -2.43 | Cheaper |
Ent. to Revenue | - | 4,101.76 | - |
PE Ratio | - | 41.26 | - |
Price to Book | 3.47 | 22.34 | Cheaper |
Dividend Yield | - | 2.39 | - |
Std. Deviation (3M) | 68.45 | 76.52 | Par |
Debt to Equity | 0.00 | 0.51 | Cheaper |
Debt to Assets | 0.00 | 0.24 | Cheaper |
Market Cap | 1.20B | 3.77B | Emerging |